JPH0380796B2 - - Google Patents

Info

Publication number
JPH0380796B2
JPH0380796B2 JP57029594A JP2959482A JPH0380796B2 JP H0380796 B2 JPH0380796 B2 JP H0380796B2 JP 57029594 A JP57029594 A JP 57029594A JP 2959482 A JP2959482 A JP 2959482A JP H0380796 B2 JPH0380796 B2 JP H0380796B2
Authority
JP
Japan
Prior art keywords
group
thiopyrano
dihydro
pyrrolidino
pyrimidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP57029594A
Other languages
English (en)
Japanese (ja)
Other versions
JPS58146586A (ja
Inventor
Sachio Oono
Seishi Mizukoshi
Osamu Komatsu
Hajime Yamamoto
Yasuo Kuno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Maruko Pharmaceutical Co Ltd
Original Assignee
Maruko Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maruko Pharmaceutical Co Ltd filed Critical Maruko Pharmaceutical Co Ltd
Priority to JP57029594A priority Critical patent/JPS58146586A/ja
Priority to AU11467/83A priority patent/AU552533B2/en
Priority to GB838304603A priority patent/GB8304603D0/en
Priority to NL8300656A priority patent/NL8300656A/nl
Priority to BE0/210188A priority patent/BE895995A/fr
Priority to IT8347764A priority patent/IT1212855B/it
Priority to KR1019830000757A priority patent/KR840003638A/ko
Priority to CA000422274A priority patent/CA1217186A/en
Priority to DE19833306485 priority patent/DE3306485A1/de
Priority to HU83641A priority patent/HU189666B/hu
Priority to SE8301038A priority patent/SE451135B/sv
Priority to ES520075A priority patent/ES520075A0/es
Priority to GB08305175A priority patent/GB2119368B/en
Priority to FR8303183A priority patent/FR2522000B1/fr
Priority to US06/469,657 priority patent/US4435566A/en
Priority to CH1077/83A priority patent/CH651305A5/de
Publication of JPS58146586A publication Critical patent/JPS58146586A/ja
Priority to ES538649A priority patent/ES8604597A1/es
Publication of JPH0380796B2 publication Critical patent/JPH0380796B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
JP57029594A 1982-02-25 1982-02-25 チオピラノピリミジン誘導体およびその酸付加塩 Granted JPS58146586A (ja)

Priority Applications (17)

Application Number Priority Date Filing Date Title
JP57029594A JPS58146586A (ja) 1982-02-25 1982-02-25 チオピラノピリミジン誘導体およびその酸付加塩
AU11467/83A AU552533B2 (en) 1982-02-25 1983-02-16 Thiopyranopyrimidines
GB838304603A GB8304603D0 (en) 1982-02-25 1983-02-18 Substituted thiopyranopyrimidine pharmaceutical compounds
NL8300656A NL8300656A (nl) 1982-02-25 1983-02-22 Thiopyranopyrimidineverbindingen en zuuradditiezouten daarvan.
BE0/210188A BE895995A (fr) 1982-02-25 1983-02-23 Composes de thiopyrannopyrimidine et leurs sels d'addition d'acide
IT8347764A IT1212855B (it) 1982-02-25 1983-02-23 Composti tiopiranopirimidinici e loro sali di addizione ccon acidi
HU83641A HU189666B (en) 1982-02-25 1983-02-24 Process for producing thiopyrano-pyrimidine derivatives and acid additional salts
CA000422274A CA1217186A (en) 1982-02-25 1983-02-24 Thiopyranopyrimidine compounds and acid addition salts thereof
DE19833306485 DE3306485A1 (de) 1982-02-25 1983-02-24 Thiopyranopyrimidin-derivate und ihre verwendung als arzneistoffe
KR1019830000757A KR840003638A (ko) 1982-02-25 1983-02-24 치오 피라노 피리미딘 화합물의 제조 방법 및 그 산(酸)부가염
SE8301038A SE451135B (sv) 1982-02-25 1983-02-24 Tiopyranopyrimidinforeningar och syraadditionssalter derav
ES520075A ES520075A0 (es) 1982-02-25 1983-02-24 Procedimiento de preparar compuestos tiopiranopirimidinicos farmacologicamente activos.
GB08305175A GB2119368B (en) 1982-02-25 1983-02-24 Substituted thiopyranopyrimidine compounds
FR8303183A FR2522000B1 (fr) 1982-02-25 1983-02-25 Nouvelles thiopyrannopyrimidines, utiles notamment comme agents hypoglycemiants, et leur fabrication
US06/469,657 US4435566A (en) 1982-02-25 1983-02-25 Thiopyranopyrimidine compounds and acid addition salts thereof
CH1077/83A CH651305A5 (de) 1982-02-25 1983-02-25 Thiopyranopyrimidin-verbindungen und deren pharmazeutisch annehmbaren saeureadditionssalze.
ES538649A ES8604597A1 (es) 1982-02-25 1984-11-30 Procedimiento de preparar compuestos tiopiranopirimidinicos farmacologicamente activos.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57029594A JPS58146586A (ja) 1982-02-25 1982-02-25 チオピラノピリミジン誘導体およびその酸付加塩

Publications (2)

Publication Number Publication Date
JPS58146586A JPS58146586A (ja) 1983-09-01
JPH0380796B2 true JPH0380796B2 (OSRAM) 1991-12-26

Family

ID=12280396

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57029594A Granted JPS58146586A (ja) 1982-02-25 1982-02-25 チオピラノピリミジン誘導体およびその酸付加塩

Country Status (4)

Country Link
JP (1) JPS58146586A (OSRAM)
AU (1) AU552533B2 (OSRAM)
BE (1) BE895995A (OSRAM)
GB (1) GB8304603D0 (OSRAM)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR910005856B1 (ko) * 1987-09-16 1991-08-05 다이호야꾸힝고오교가부시끼가이샤 티에노피리미딘 유도체

Also Published As

Publication number Publication date
GB8304603D0 (en) 1983-03-23
AU552533B2 (en) 1986-06-05
AU1146783A (en) 1983-09-01
BE895995A (fr) 1983-06-16
JPS58146586A (ja) 1983-09-01

Similar Documents

Publication Publication Date Title
CN106008340B (zh) 稠环衍生物、其制备方法、中间体、药物组合物及应用
NO162965B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive alfa-(2-okso-2,4,5,6,7,7a-heksahydrotieno-(3,2-c)-5-pyridyl)-fenyl-eddiksyre-derivater.
JP2021513982A (ja) Ｐ３００／ｃｂｐ ｈａｔ阻害剤及びそれらの使用の方法
JPH0283375A (ja) ２−置換ピペラジニル−２−（１，２−ベンズイソキサゾール−３−イル）酢酸誘導体
US4243666A (en) 4-Amino-2-piperidino-quinazolines
EP1598346A1 (en) Process for producing acid adduct salt of polyacidic base compound
JPS6140674B2 (OSRAM)
KR940006633B1 (ko) 광학 활성 티에노트리아졸로디아제핀 화합물
JPS6383052A (ja) アミノフエノ−ル誘導体
JPH03106875A (ja) １―（３―ピリジルメチル）フタラジン誘導体
JPH0380796B2 (OSRAM)
Huang et al. Design, synthesis, and biological evaluation of novel (E)-1-arylethan-1-one O-((3-arylisoxazol-5-yl) methyl) oxime derivatives as potent non-nucleoside HBV inhibitors
JPH0733743A (ja) ２−アリール−４−キノリノール誘導体
PT88780B (pt) Processo para a preparacao de derivados de imidazol
GB2171997A (en) 4-Amino-6,7-dimethoxy-2-Piperazin-1-ylquinazoline derivatives
US5310750A (en) Heterocyclic compounds useful as α2 -adrenoceptor antagonists
FI62664B (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 6-piperazinyl-11-metylen-morfantridin-derivat
US3965106A (en) 3-Phenoxypropylamine derivatives
SU895291A3 (ru) Способ получени производных 4-амино-2-пиперидинохиназолина или их солей с фармацевтически приемлимыми кислотами
JPS61268680A (ja) 新規なイソオキサゾール誘導体
US4866176A (en) 8-Piperazinyl-1,7-naphthyridine derivative having pharmaceutical activity
JPS62221679A (ja) ベンゾチアゾリン誘導体
US4746663A (en) Pyrazolo[4,3-d]pyrimidine derivative, process for its production, and antihyperlipidemic or antiatherosclerotic agent containing it
JPS5857379A (ja) ５，６，７，８−テトラヒドロ−１，６−ナフチリジン誘導体およびその製造法
JPH01132519A (ja) 細胞保護剤としての１（２ｈ）−フタラジノン